Loading...
XASX
ADR
Market cap1mUSD
Aug 24, Last price  
0.10AUD
Name

Adherium Ltd

Chart & performance

D1W1MN
XASX:ADR chart
P/E
P/S
2.36
EPS
Div yield, %
Shrs. gr., 5y
111.89%
Rev. gr., 5y
-18.10%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Adherium Limited specializes in developing, manufacturing, and providing advanced digital health solutions. The company's core mission is to enhance medication adherence for individuals managing chronic conditions in key international markets, spanning New Zealand, Australia, Europe, North America, and Asia. A central offering is Hailie, a comprehensive system engineered to optimize medication use for patients suffering from chronic respiratory illnesses like asthma and chronic obstructive pulmonary disease (COPD). This innovative solution integrates Bluetooth-enabled Hailie sensors, which discreetly attach to patients' inhalers to deliver immediate feedback. The Hailie ecosystem is further supported by an intuitive mobile application and a dedicated online portal. Established in 2001, Adherium Limited is headquartered in Auckland, New Zealand.
IPO date
Aug 26, 2015
Employees
Domiciled in
NZ
Incorporated in
AU

Valuation

No data to show